James N. Wilson, Director at CORCEPT THERAPEUTICS INC (CORT), sold 15,000 shares at $4.31 ($65K) on 2011-05-02, disclosed to the SEC on 2011-05-03.
Scheduled sale ($65k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.31 | 10,000 | $43K | 66.6% |
| 2 | $4.33 | 5,000 | $22K | 33.4% |
| Total | $4.32 avg | 15,000 | $65K | 100% |
| Filing → |
| CORT | SELL | 2026-07-17 | $883K | — | Filing → |
| CORT | SELL | 2026-06-18 | $832K | — | Filing → |
| CORT | SELL | 2016-11-14 | $1.4M | — | Filing → |